Search hospitals > Texas > Austin
Texas Oncology Cancer Center
Claim this profileAustin, Texas 78731
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Ovarian Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Ovarian Tumors
143 reported clinical trials
10 medical researchers
Summary
Texas Oncology Cancer Center is a medical facility located in Austin, Texas. This center is recognized for care of Breast Cancer, Cancer, Ovarian Cancer, Non-Small Cell Lung Cancer, Ovarian Tumors and other specialties. Texas Oncology Cancer Center is involved with conducting 143 clinical trials across 146 conditions. There are 10 research doctors associated with this hospital, such as Jason M Melear, Debra Patt, Michael Teneriello, and Vivian Cline, MD.Area of expertise
1Breast Cancer
Global LeaderStage IV
Stage III
HER2 negative
2Cancer
Global LeaderStage IV
Stage III
BRCA2 positive
Top PIs
Jason M MelearTexas Oncology - Austin Midtown5 years of reported clinical research
Studies Lymphoma
Studies Multiple Myeloma
20 reported clinical trials
35 drugs studied
Debra PattTexas Oncology - Austin Central3 years of reported clinical research
Expert in Breast Cancer
Studies Cancer
14 reported clinical trials
24 drugs studied
Michael TenerielloTexas Oncology - Austin Central4 years of reported clinical research
Studies Ovarian Cancer
Studies Ovarian Tumors
12 reported clinical trials
26 drugs studied
Vivian Cline, MDTexas Oncology - Austin11 years of reported clinical research
Studies Colorectal Cancer
Studies Pancreatic Cancer
8 reported clinical trials
21 drugs studied
Clinical Trials running at Texas Oncology Cancer Center
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
Tumors
Mantle Cell Lymphoma
Gallbladder Cancer
Biliary Tract Cancer
Bladder Cancer
Endometrial Cancer
Giredestrant + Phesgo
for Breast Cancer
This Phase III, randomized, two-arm, open-label, multicenter study will evaluate the efficacy and safety of giredestrant plus Phesgo compared with Phesgo after induction therapy with Phesgo plus taxane in participants with human epidermal growth factor receptor 2 (HER2)-positive, estrogen receptor (ER)-positive advanced breast cancer (metastatic or locally advanced disease not amenable to curative treatment) who have not previously received a systemic non-hormonal anti-cancer therapy in the advanced setting.
Recruiting2 awards Phase 311 criteria
Gedatolisib + Fulvestrant +/- Palbociclib
for Advanced Breast Cancer
This is a Phase 3, open-label, randomized, clinical trial evaluating the efficacy and safety of gedatolisib plus fulvestrant with or without palbociclib for the treatment of patients with locally advanced or metastatic HR+/HER2- breast cancer following progression on or after CDK4/6 and aromatase inhibitor therapy.
Recruiting2 awards Phase 311 criteria
Imlunestrant + Abemaciclib
for Breast Cancer
This study is evaluating whether a drug called LY3484356 can help treat breast cancer.
Recruiting2 awards Phase 39 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Texas Oncology Cancer Center?
Texas Oncology Cancer Center is a medical facility located in Austin, Texas. This center is recognized for care of Breast Cancer, Cancer, Ovarian Cancer, Non-Small Cell Lung Cancer, Ovarian Tumors and other specialties. Texas Oncology Cancer Center is involved with conducting 143 clinical trials across 146 conditions. There are 10 research doctors associated with this hospital, such as Jason M Melear, Debra Patt, Michael Teneriello, and Vivian Cline, MD.